Report cover image

Cancer Clinical Decision Tools Global Market Report 2025

Published Apr 09, 2025
Length 250 Pages
SKU # BRC19913368

Description

Cancer Clinical Decision Tools Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cancer clinical decision tools market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for cancer clinical decision tools ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cancer clinical decision tools market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Type: Risk Assessment Tool(RAT); Qcancer

2) By End-User: Hospital; Clinics

Subsegments:

1) By Risk Assessment Tool (RAT): Family History Assessment; Genetic Testing and Counseling; Lifestyle and Environmental Risk Factors Evaluation

2) By Qcancer: Symptom Checker; Risk Calculator; Guideline-Based Recommendations

Companies Mentioned: McKesson Corporation; Medical Information Technology Inc.; Philips Healthcare; Siemens Healthineers AG; Elsevier B.V.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Table of Contents

250 Pages
1. Executive Summary
2. Cancer Clinical Decision Tools Market Characteristics
3. Cancer Clinical Decision Tools Market Trends And Strategies
4. Cancer Clinical Decision Tools Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Cancer Clinical Decision Tools Growth Analysis And Strategic Analysis Framework
5.1. Global Cancer Clinical Decision Tools PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Cancer Clinical Decision Tools Market Growth Rate Analysis
5.4. Global Cancer Clinical Decision Tools Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Cancer Clinical Decision Tools Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Cancer Clinical Decision Tools Total Addressable Market (TAM)
6. Cancer Clinical Decision Tools Market Segmentation
6.1. Global Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Risk Assessment Tool (RAT)
Qcancer
6.2. Global Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital
Clinics
6.3. Global Cancer Clinical Decision Tools Market, Sub-Segmentation Of Risk Assessment Tool (RAT), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Family History Assessment
Genetic Testing and Counseling
Lifestyle and Environmental Risk Factors Evaluation
6.4. Global Cancer Clinical Decision Tools Market, Sub-Segmentation Of Qcancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Symptom Checker
Risk Calculator
Guideline-Based Recommendations
7. Cancer Clinical Decision Tools Market Regional And Country Analysis
7.1. Global Cancer Clinical Decision Tools Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Cancer Clinical Decision Tools Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Cancer Clinical Decision Tools Market
8.1. Asia-Pacific Cancer Clinical Decision Tools Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Cancer Clinical Decision Tools Market
9.1. China Cancer Clinical Decision Tools Market Overview
9.2. China Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Cancer Clinical Decision Tools Market
10.1. India Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Cancer Clinical Decision Tools Market
11.1. Japan Cancer Clinical Decision Tools Market Overview
11.2. Japan Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Cancer Clinical Decision Tools Market
12.1. Australia Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Cancer Clinical Decision Tools Market
13.1. Indonesia Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Cancer Clinical Decision Tools Market
14.1. South Korea Cancer Clinical Decision Tools Market Overview
14.2. South Korea Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Cancer Clinical Decision Tools Market
15.1. Western Europe Cancer Clinical Decision Tools Market Overview
15.2. Western Europe Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Cancer Clinical Decision Tools Market
16.1. UK Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Cancer Clinical Decision Tools Market
17.1. Germany Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Cancer Clinical Decision Tools Market
18.1. France Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Cancer Clinical Decision Tools Market
19.1. Italy Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Cancer Clinical Decision Tools Market
20.1. Spain Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Cancer Clinical Decision Tools Market
21.1. Eastern Europe Cancer Clinical Decision Tools Market Overview
21.2. Eastern Europe Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Cancer Clinical Decision Tools Market
22.1. Russia Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Cancer Clinical Decision Tools Market
23.1. North America Cancer Clinical Decision Tools Market Overview
23.2. North America Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Cancer Clinical Decision Tools Market
24.1. USA Cancer Clinical Decision Tools Market Overview
24.2. USA Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Cancer Clinical Decision Tools Market
25.1. Canada Cancer Clinical Decision Tools Market Overview
25.2. Canada Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Cancer Clinical Decision Tools Market
26.1. South America Cancer Clinical Decision Tools Market Overview
26.2. South America Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Cancer Clinical Decision Tools Market
27.1. Brazil Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Cancer Clinical Decision Tools Market
28.1. Middle East Cancer Clinical Decision Tools Market Overview
28.2. Middle East Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Cancer Clinical Decision Tools Market
29.1. Africa Cancer Clinical Decision Tools Market Overview
29.2. Africa Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Cancer Clinical Decision Tools Market Competitive Landscape And Company Profiles
30.1. Cancer Clinical Decision Tools Market Competitive Landscape
30.2. Cancer Clinical Decision Tools Market Company Profiles
30.2.1. McKesson Corporation Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Medical Information Technology Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Philips Healthcare Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Elsevier B.V. Overview, Products and Services, Strategy and Financial Analysis
31. Cancer Clinical Decision Tools Market Other Major And Innovative Companies
31.1. Macmillan Publishers Limited
31.2. National Decision Support Company
31.3. IBM Watson Health
31.4. Cerner Corporation
31.5. GE Healthcare
31.6. Allscripts Healthcare Solutions Inc.
31.7. Epic Systems Corporation
31.8. Koninklijke Philips N.V.
31.9. RaySearch Laboratories AB
31.10. Elekta AB
31.11. Varian Medical Systems Inc.
31.12. Accuray Incorporated
31.13. F. Hoffmann-La Roche Ltd.
31.14. Flatiron Health Inc.
31.15. Tempus Labs Inc.
32. Global Cancer Clinical Decision Tools Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Cancer Clinical Decision Tools Market
34. Recent Developments In The Cancer Clinical Decision Tools Market
35. Cancer Clinical Decision Tools Market High Potential Countries, Segments and Strategies
35.1 Cancer Clinical Decision Tools Market In 2029 - Countries Offering Most New Opportunities
35.2 Cancer Clinical Decision Tools Market In 2029 - Segments Offering Most New Opportunities
35.3 Cancer Clinical Decision Tools Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.